Portage Biotech
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -8 | -15 | ||
EBITDA | -1,604 | -2,839 | -48,715 | |
EBIT | -1,611 | -2,847 | -3,260 | -48,730 |
Net Income | -1,360 | -1,656 | -24,889 | -39,373 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,560 | -1,686 | -3,121 | -3,334 |
Cash | 1,764 | 3,334 | 5,028 | 5,341 |
Basic Shares | 1,076 | 1,049 | 989 | 20,897 |
Annual Financials
| Values in thousands | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -54 | -1 | ||
EBITDA | -18,199 | -15,775 | -15,588 | |
EBIT | -7,418 | -18,253 | -15,776 | -31,176 |
Net Income | -6,767 | -75,339 | -104,611 | -16,870 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,462 | -14,297 | -12,076 | -6,764 |
Cash | 1,670 | 5,028 | 10,545 | 23,352 |
Basic Shares | 1,653 | 20,341 | 16,119 | 13,060 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$2.88 |
2024-09-30 | -$1.26 |
2024-06-30 | -$1.25 |
2024-03-31 | -$24.20 |
